Procter & GambleProcter & GambleProcter & Gamble

Procter & Gamble

No trades
See on Supercharts

Key facts today


Procter & Gamble's Q2 results exceeded expectations, showing revenue growth in most segments. UBS maintains its fiscal 2025 earnings estimate and buy rating, with a price target of $189.
DA Davidson has maintained a 'Buy' rating for Procter & Gamble, setting a price target of $209.00 per share.
Analyze the impactAnalyze the impact

About Procter & Gamble Company (The)


The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies. It offers products under the brands, such as Olay, Old Spice, Safeguard, Head & Shoulders, Pantene, Rejoice, Mach3, Prestobarba, Venus, Cascade, Dawn, Febreze, Mr. Clean, Bounty and Charmin.

See all ideas 

Displays a symbol's price movements over previous years to identify recurring trends.